2023 Q4 Form 10-Q Financial Statement

#000095017023058687 Filed on November 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $122.7M $123.9M $143.6M
YoY Change -8.48% -13.7% -10.03%
Cost Of Revenue $115.8M $116.3M $131.2M
YoY Change -7.71% -11.41% -7.25%
Gross Profit $6.853M $7.649M $12.35M
YoY Change -19.74% -38.05% -31.79%
Gross Profit Margin 5.59% 6.17% 8.6%
Selling, General & Admin $10.98M $9.911M $10.42M
YoY Change 4.18% -4.88% 9.21%
% of Gross Profit 160.16% 129.57% 84.38%
Research & Development $7.272M $7.637M $6.826M
YoY Change 1.37% 11.88% 47.59%
% of Gross Profit 106.11% 99.84% 55.28%
Depreciation & Amortization $5.713M $5.338M $4.362M
YoY Change 22.33% 22.38% 3.86%
% of Gross Profit 83.36% 69.79% 35.33%
Operating Expenses $18.25M $17.55M $17.25M
YoY Change 3.04% 1.76% 21.74%
Operating Profit -$11.40M -$9.899M -$4.897M
YoY Change 24.24% 102.14% -224.35%
Interest Expense $111.0K $111.0K $226.0K
YoY Change -47.89% -50.88% -17.22%
% of Operating Profit
Other Income/Expense, Net $38.00K $29.00K -$23.00K
YoY Change -522.22% -226.09% -675.0%
Pretax Income -$11.30M -$9.815M -$5.139M
YoY Change 20.46% 90.99% -240.07%
Income Tax $300.0K $800.0K -$600.0K
% Of Pretax Income
Net Earnings -$11.55M -$10.57M -$4.517M
YoY Change 44.81% 133.89% -246.04%
Net Earnings / Revenue -9.42% -8.53% -3.15%
Basic Earnings Per Share -$0.21 -$0.19 -$0.08
Diluted Earnings Per Share -$0.21 -$0.19 -$0.08
COMMON SHARES
Basic Shares Outstanding 54.58M 54.59M 53.38M
Diluted Shares Outstanding 54.76M 54.47M 53.35M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.52M $56.31M $88.38M
YoY Change -42.46% -36.29% -16.56%
Cash & Equivalents $45.52M $56.31M $88.38M
Short-Term Investments
Other Short-Term Assets $7.832M $8.690M $5.212M
YoY Change 50.21% 66.73% -38.44%
Inventory
Prepaid Expenses
Receivables $74.73M $67.68M $75.49M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $128.1M $132.7M $169.1M
YoY Change -17.76% -21.53% -16.63%
LONG-TERM ASSETS
Property, Plant & Equipment $20.60M $19.50M $11.23M
YoY Change 57.66% 73.69% 53.13%
Goodwill $121.1M $121.1M $121.1M
YoY Change 0.0% 0.0% 2.8%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.640M $5.713M $6.087M
YoY Change -9.77% -6.14% -87.32%
Total Long-Term Assets $192.8M $188.3M $236.4M
YoY Change -18.35% -20.37% -1.12%
TOTAL ASSETS
Total Short-Term Assets $128.1M $132.7M $169.1M
Total Long-Term Assets $192.8M $188.3M $236.4M
Total Assets $320.9M $321.0M $405.5M
YoY Change -18.11% -20.85% -8.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $33.78M $34.29M $40.92M
YoY Change -10.72% -16.2% -15.38%
Accrued Expenses $44.54M $41.32M $51.05M
YoY Change -4.93% -19.06% 4.41%
Deferred Revenue $0.00 $0.00 $48.00K
YoY Change -100.0% -100.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $85.04M $83.26M $104.4M
YoY Change -11.58% -20.23% -5.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.57M $11.33M $15.00M
YoY Change -18.4% -24.52% -52.79%
Total Long-Term Liabilities $11.57M $11.33M $15.00M
YoY Change -18.4% -24.52% -52.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $85.04M $83.26M $104.4M
Total Long-Term Liabilities $11.57M $11.33M $15.00M
Total Liabilities $105.7M $98.63M $122.3M
YoY Change -5.74% -19.34% -14.04%
SHAREHOLDERS EQUITY
Retained Earnings -$121.2M -$109.6M -$34.73M
YoY Change 183.77% 215.7%
Common Stock $336.7M $332.2M $318.3M
YoY Change 4.32% 4.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $215.3M $222.3M $283.3M
YoY Change
Total Liabilities & Shareholders Equity $320.9M $321.0M $405.5M
YoY Change -18.11% -20.85% -8.24%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$11.55M -$10.57M -$4.517M
YoY Change 44.81% 133.89% -246.04%
Depreciation, Depletion And Amortization $5.713M $5.338M $4.362M
YoY Change 22.33% 22.38% 3.86%
Cash From Operating Activities -$3.654M -$4.973M $5.665M
YoY Change 48.24% -187.78% -1.53%
INVESTING ACTIVITIES
Capital Expenditures $4.283M $1.624M $476.0K
YoY Change 7.59% 241.18% 16.38%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$4.283M -$5.094M -$3.037M
YoY Change 4.44% 67.73% 121.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.854M -7.311M -10.68M
YoY Change 5.59% -31.55% 21.87%
NET CHANGE
Cash From Operating Activities -3.654M -4.973M 5.665M
Cash From Investing Activities -4.283M -5.094M -3.037M
Cash From Financing Activities -2.854M -7.311M -10.68M
Net Change In Cash -10.79M -17.37M -8.057M
YoY Change 16.42% 115.61% 83.53%
FREE CASH FLOW
Cash From Operating Activities -$3.654M -$4.973M $5.665M
Capital Expenditures $4.283M $1.624M $476.0K
Free Cash Flow -$7.937M -$6.597M $5.189M
YoY Change 23.13% -227.13% -2.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001117297
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2023Q3 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q3 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
001-34628
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
QuinStreet, Inc.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0512121
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
950 Tower Lane
CY2023Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
6th Floor
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Foster City
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94404
CY2023Q3 dei City Area Code
CityAreaCode
650
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
578-7700
CY2023Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q3 dei Trading Symbol
TradingSymbol
QNST
CY2023Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54579044
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56305000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73677000
CY2023Q3 qnst Financing Receivable Allowance For Credit Losses And Revenue Reserve
FinancingReceivableAllowanceForCreditLossesAndRevenueReserve
3716000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
329093000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-268000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-266000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-109645000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99080000
CY2023Q2 qnst Financing Receivable Allowance For Credit Losses And Revenue Reserve
FinancingReceivableAllowanceForCreditLossesAndRevenueReserve
3722000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67684000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67748000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8690000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9779000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
132679000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
151204000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19504000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16749000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5806000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3536000
CY2023Q3 us-gaap Goodwill
Goodwill
121141000
CY2023Q2 us-gaap Goodwill
Goodwill
121141000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36122000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38700000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5713000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5825000
CY2023Q3 us-gaap Assets
Assets
320965000
CY2023Q2 us-gaap Assets
Assets
337155000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
34286000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
37926000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41322000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44010000
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7649000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7875000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
83257000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
89820000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4047000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1261000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11325000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16273000
CY2023Q3 us-gaap Liabilities
Liabilities
98629000
CY2023Q2 us-gaap Liabilities
Liabilities
107354000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54648886
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54648886
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54192928
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54192928
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
55000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
54000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
332194000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
229801000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
416000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
222336000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
229801000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
320965000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
337155000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
123923000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
143593000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
116274000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
131245000
CY2023Q3 us-gaap Gross Profit
GrossProfit
7649000
CY2022Q3 us-gaap Gross Profit
GrossProfit
12348000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7637000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6826000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3124000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3100000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6787000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7319000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9899000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4897000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
166000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
CY2023Q3 us-gaap Interest Expense
InterestExpense
111000
CY2022Q3 us-gaap Interest Expense
InterestExpense
226000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9815000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5139000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
750000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-622000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10565000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4517000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54470000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53350000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54470000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53350000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10565000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4517000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10567000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4522000
CY2023Q3 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3470000
CY2022Q3 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2561000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1164000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5288000
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2188000
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1578000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10565000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
222336000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
286000000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
236000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1324000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5284000
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2016000
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3050000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4517000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
283256000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10565000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4517000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5338000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4362000
CY2023Q3 qnst Provision For Sales Returns And Doubtful Accounts Receivable
ProvisionForSalesReturnsAndDoubtfulAccountsReceivable
223000
CY2022Q3 qnst Provision For Sales Returns And Doubtful Accounts Receivable
ProvisionForSalesReturnsAndDoubtfulAccountsReceivable
120000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
5275000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
5270000
CY2023Q3 qnst Non Cash Lease Expense
NonCashLeaseExpense
-253000
CY2022Q3 qnst Non Cash Lease Expense
NonCashLeaseExpense
-262000
CY2023Q3 qnst Deferred Income Taxes
DeferredIncomeTaxes
544000
CY2022Q3 qnst Deferred Income Taxes
DeferredIncomeTaxes
-802000
CY2023Q3 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-438000
CY2022Q3 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-147000
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
159000
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5822000
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1089000
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
426000
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3603000
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1868000
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2525000
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1594000
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-9000
CY2022Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-293000
CY2023Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
110000
CY2022Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4973000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5665000
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1624000
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
476000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5094000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3037000
CY2023Q3 qnst Proceeds From Stock Options Exercised And Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromStockOptionsExercisedAndIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
1579000
CY2022Q3 qnst Proceeds From Stock Options Exercised And Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromStockOptionsExercisedAndIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
1560000
CY2023Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2187000
CY2022Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2016000
CY2023Q3 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
5277000
CY2022Q3 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
5494000
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1426000
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4731000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7311000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10681000
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6000
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17372000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8057000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
73692000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
96453000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56320000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88396000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56305000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88382000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
15000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56320000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88396000
CY2023Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
84000
CY2022Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
73000
CY2023Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1660000
CY2022Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1036000
CY2023Q3 qnst Treasury Stock Retired Carrying Value
TreasuryStockRetiredCarryingValue
-1578000
CY2022Q3 qnst Treasury Stock Retired Carrying Value
TreasuryStockRetiredCarryingValue
-3050000
CY2023Q3 us-gaap Nature Of Operations
NatureOfOperations
<p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. The Company</span></p><p style="text-indent:2.267%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">QuinStreet, Inc. (the “Company”) is a leader in performance marketplaces and technologies for the financial services and home services industries. The Company was incorporated in California in April 1999 and reincorporated in Delaware in December 2009. The Company specializes in customer acquisition for clients in high value, information-intensive markets or “verticals,” including financial services and home services. The corporate headquarters are located in Foster City, California, with additional offices throughout the United States and India. The majority of the Company’s operations and revenue are in North America.</span></p>
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:2.267%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the period. On an ongoing basis, management evaluates these estimates, judgments and assumptions, including those related to revenue recognition, stock-based compensation, goodwill, long-lived assets, contingencies, credit losses of accounts receivable, and income taxes. The Company bases these estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. In addition, the Company may engage third-party valuation specialists to assist with the preparation of certain of its valuations. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenue and expenses that are not readily apparent from other sources. Actual results could differ from those estimates, and such differences could affect the results of operations reported in future periods.</span></p>
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2100000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2100000
CY2023Q3 qnst Revenue Reserve
RevenueReserve
1600000
CY2023Q2 qnst Revenue Reserve
RevenueReserve
1600000
CY2023Q3 qnst Financing Receivable Allowance For Credit Losses And Revenue Reserve
FinancingReceivableAllowanceForCreditLossesAndRevenueReserve
3700000
CY2023Q2 qnst Financing Receivable Allowance For Credit Losses And Revenue Reserve
FinancingReceivableAllowanceForCreditLossesAndRevenueReserve
3700000
CY2023Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:2.267%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span></p><p style="text-indent:2.267%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> client that accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of net revenue for the three months ended September 30, 2022. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> other clients accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% or more of net revenue for the three months ended September 30, 2023 or 2022 or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% or more of net accounts receivable as of September 30, 2023 or June 30, 2023.</span></p>
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-600000
CY2023Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P7Y
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
123923000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
143593000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9000
CY2023Q3 qnst Contract With Customer Prepaid Liability Current
ContractWithCustomerPrepaidLiabilityCurrent
1096000
CY2023Q2 qnst Contract With Customer Prepaid Liability Current
ContractWithCustomerPrepaidLiabilityCurrent
1213000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1096000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1222000
CY2023Q3 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
3600000
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3500000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10565000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4517000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54470000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53350000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54470000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53350000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54470000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53350000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4494000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4236000
CY2023Q3 qnst Fair Value Of Assets Level1 To Level2 Transfers Amount
FairValueOfAssetsLevel1ToLevel2TransfersAmount
0
CY2023Q2 qnst Fair Value Of Assets Level1 To Level2 Transfers Amount
FairValueOfAssetsLevel1ToLevel2TransfersAmount
0
CY2023Q3 qnst Fair Value Of Assets Level2 To Level1 Transfers Amount
FairValueOfAssetsLevel2ToLevel1TransfersAmount
0
CY2023Q2 qnst Fair Value Of Assets Level2 To Level1 Transfers Amount
FairValueOfAssetsLevel2ToLevel1TransfersAmount
0
CY2023Q3 qnst Fair Value Of Liabilities Level1 To Level2 Transfers Amount
FairValueOfLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2023Q2 qnst Fair Value Of Liabilities Level1 To Level2 Transfers Amount
FairValueOfLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2023Q3 qnst Fair Value Of Liabilities Level2 To Level1 Transfers Amount
FairValueOfLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2023Q2 qnst Fair Value Of Liabilities Level2 To Level1 Transfers Amount
FairValueOfLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2023Q3 qnst Fair Value Liabilities Level3 To Level1 Transfers Amount
FairValueLiabilitiesLevel3ToLevel1TransfersAmount
0
CY2023Q2 qnst Fair Value Liabilities Level3 To Level1 Transfers Amount
FairValueLiabilitiesLevel3ToLevel1TransfersAmount
0
CY2023Q3 qnst Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2023Q2 qnst Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8155000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1560000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6595000
CY2023Q3 us-gaap Goodwill
Goodwill
121100000
CY2023Q2 us-gaap Goodwill
Goodwill
121100000
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
195041000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
158919000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36122000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
195041000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
156341000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38700000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2600000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2800000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7631000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8069000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5461000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4500000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4037000
CY2023Q3 qnst Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
6425000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36122000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1450000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1226000
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
176000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
169000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
210000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
143000
CY2023Q3 us-gaap Lease Cost
LeaseCost
1836000
CY2022Q3 us-gaap Lease Cost
LeaseCost
1538000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1464000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1470000
CY2023Q3 qnst Increase In Operating Lease Liability In Exchange For Right Of Use Asset Obtained
IncreaseInOperatingLeaseLiabilityInExchangeForRightOfUseAssetObtained
3519000
CY2022Q3 qnst Increase In Operating Lease Liability In Exchange For Right Of Use Asset Obtained
IncreaseInOperatingLeaseLiabilityInExchangeForRightOfUseAssetObtained
328000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2541000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1777000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1080000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
896000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
829000
CY2023Q3 qnst Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1032000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2548000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4047000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6595000
CY2023Q3 qnst Additional Operating Leases Undiscounted Future Minimum Payments Amount
AdditionalOperatingLeasesUndiscountedFutureMinimumPaymentsAmount
8400000
CY2023Q3 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P5Y
CY2023Q3 qnst Liabilities Related To Indemnification Agreement
LiabilitiesRelatedToIndemnificationAgreement
0
CY2023Q2 qnst Liabilities Related To Indemnification Agreement
LiabilitiesRelatedToIndemnificationAgreement
0
CY2023Q2 qnst Accrual For Indemnification Provisions
AccrualForIndemnificationProvisions
0
CY2023Q3 qnst Accrual For Indemnification Provisions
AccrualForIndemnificationProvisions
0
CY2023Q3 qnst Letters Of Credit For Fidelity Bonds
LettersOfCreditForFidelityBonds
500000
CY2023Q3 qnst Period Of Cancellation Of Letter Of Credit From Annual Expiration Date
PeriodOfCancellationOfLetterOfCreditFromAnnualExpirationDate
P30D
CY2023Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
123923000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
143593000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19504000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16749000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36122000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38700000
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000950170-23-058687-index-headers.html Edgar Link pending
0000950170-23-058687-index.html Edgar Link pending
0000950170-23-058687.txt Edgar Link pending
0000950170-23-058687-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qnst-20230930.htm Edgar Link pending
qnst-20230930.xsd Edgar Link pending
qnst-ex31_1.htm Edgar Link pending
qnst-ex31_2.htm Edgar Link pending
qnst-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qnst-20230930_lab.xml Edgar Link unprocessable
qnst-20230930_pre.xml Edgar Link unprocessable
qnst-20230930_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
qnst-20230930_cal.xml Edgar Link unprocessable
qnst-20230930_def.xml Edgar Link unprocessable